A look at the day's big movers
CAI International Inc (NYSE:CAI), up 17% at US$36.68
Transportation and logistics company CAI was going places in early trades, after it reported net income for the third quarter of US$69.1mln, versus a loss of US$5.5mln the year before.
The manufacturer of high-purity poly-silicon for the global solar photo-voltaic industry said its board has officially approved the company's Phase 3B expansion plan for its poly-silicon facilities in Xinjiang.
NCR Corporation (NYSE:NCR), down 11% at US$33.04
The cash dispensing machine maker said orders for automatic telling machines (ATMs) in the third quarter were disappointing, resulting in the company reducing full-year guidance.
Supervalu Inc (NYSE:SVU), down 7% at US$14.60
The wholesale distributor made a net loss of US$25mln in the 12 weeks to 9 September, versus a profit of US$31mln in the corresponding period of last year. It also announced it was buying Associated Grocers of Florida for US$180mln.
Online payments specialist Paypal Holdings Inc (NASDAQ:PYPL) was wanted in after-hours trading after topping expectations with its earnings.
The firm also raised its outlook for the full year, now expecting revenues in the range of between US$12.92bn and US$12.98bn.
The shares were up almost 4% at US$69.84 in screen-based trading.
Third quarter earnings per share of 59 cents were 16 cents higher than the market had been expecting.
“Third quarter net sales of US$1.095 billion set a new quarterly record for the Company, surpassing our previous record in the first quarter earlier this year by $22 million, and resulted in a new nine month record with sales exceeding $3 billion,” said David Weinberg, chief operating officer and chief financial officer of Skechers.
Total revenue in the three months to the end of September was US$193.8, up 42% from US$136.8 million for the first quarter of fiscal 2017.
Adjusted net income was US$29.9mln, versus US$22.7mln the year before.
The shares retreated 5.5% to US$128.50 after the company announced it would not take a possible Crohn’s disease treatment to Phase 3 trial.
Medtech firm Intuitive Surgical Inc (NASDAQ:ISRG) found the market hard to please.
The shares dipped 3.2% to US$345.90, despite reporting third quarter revenues and profits that beat Wall Street's consensus forecasts.
Net income weighed in at US$323.8mln, equivalent to US$2.77 a share; that was up from US$245.7mln (US$2.06 a share) the year before ans better than the US$1.99 a share analysts had been expecting.